
Whitehawk Therapeutics, Inc. — Investor Relations & Filings
Whitehawk Therapeutics, Inc. is a preclinical-stage oncology company focused on developing advanced antibody-drug conjugate (ADC) therapies. The company applies next-wave platform technologies to established tumor biology to create treatments for difficult-to-treat cancers. Its portfolio features three ADC assets, which are engineered to overcome the limitations of first-generation predecessors through improved tumor targeting and clinical strategies. These assets are in-licensed from WuXi Biologics under an exclusive agreement for global development and commercialization.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| S-3 | 2026-05-29 | English | |
| 8-K | 2026-05-21 | English | |
| 8-K - Whitehawk Therapeutics, Inc. (0001422142) (Filer) | 2026-05-13 | English | |
| 8-K - Whitehawk Therapeutics, Inc. (0001422142) (Filer) | 2026-05-07 | English | |
| 3 Filing | 2025-12-02 | English | |
| 4 Filing | 2025-12-02 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
4 filings
| |||||
| 47894348 | S-3 | 2026-05-29 | English | ||
| 46754058 | 8-K | 2026-05-21 | English | ||
| 45579684 | 8-K - Whitehawk Therapeutics, Inc. (0001422142) (Filer) | 2026-05-13 | English | ||
| 42980779 | 8-K - Whitehawk Therapeutics, Inc. (0001422142) (Filer) | 2026-05-07 | English | ||
|
2025
11 filings
| |||||
| 29677370 | 3 Filing | 2025-12-02 | English | ||
| 29675686 | 4 Filing | 2025-12-02 | English | ||
| 29677454 | 10-Q Filing | 2025-11-06 | English | ||
| 29675803 | 8-K Filing | 2025-11-06 | English | ||
| 29677316 | SCHEDULE 13G Filing | 2025-08-25 | English | ||
| 29677462 | 10-Q Filing | 2025-08-07 | English | ||
| 29677395 | 8-K Filing | 2025-08-07 | English | ||
| 29675718 | 4 Filing | 2025-06-17 | English | ||
| 29675501 | 4 Filing | 2025-06-17 | English | ||
| 29677439 | 4 Filing | 2025-06-16 | English | ||
| 29677425 | 4 Filing | 2025-06-16 | English | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Vaxil Bio Ltd.
Uses a proprietary Signal Peptide platform to develop immun…
|
VXL | CA | Professional, scientific and te… |
|
Vcanbio Cell & Gene Engineering Corp., Ltd
Focuses on stem cell bio-banking, genetic testing, and cell…
|
600645 | CN | Professional, scientific and te… |
|
VECTUS BIOSYSTEMS LIMITED
Develops therapeutics to reverse fibrosis and hypertension …
|
VBS | AU | Professional, scientific and te… |
|
Veradermics, Inc
Clinical-stage biopharmaceutical company developing medical…
|
MANE | US | Professional, scientific and te… |
|
Vera Therapeutics, Inc.
Clinical-stage biotech developing treatments for immunologi…
|
VERA | US | Professional, scientific and te… |
|
Veritas In Silico Inc.
A drug discovery company developing mRNA-targeting therapeu…
|
130A | JP | Professional, scientific and te… |
|
ViGenCell Inc.
Develops immune cell therapies to treat cancer and other in…
|
308080 | KR | Professional, scientific and te… |
|
Viking Therapeutics, Inc.
Clinical-stage biopharma developing therapies for metabolic…
|
VKTX | US | Professional, scientific and te… |
|
Vimta Labs Ltd.
Contract research and testing organization for life science…
|
VIMTALABS | IN | Professional, scientific and te… |
|
Vinext S.p.A.
Develops sustainable technology for the oenology and agri-f…
|
VNXT | IT | Professional, scientific and te… |
Whitehawk Therapeutics, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34276/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34276 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34276 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34276 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34276}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Whitehawk Therapeutics, Inc. (id: 34276)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.